Skip to main navigation Skip to search Skip to main content

An Open-Label, Proof of Concept Study Designed to Evaluate the Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients with Newly Diagnosed, Moderate to Extensive Bullous Pemphigoid

Project: Research

Project Details

StatusFinished
Effective start/end date09/9/16 → 09/9/19

Funding

  • Immune Pharmaceuticals: $11,900.00